Level D· Scientific groundwork from lab and animal studiesNarrative ReviewEurope PMCOpen access

The effects and mechanisms of stem cells and exosomes on neurological function protection and recovery after ischemic stroke

Du W., He Y., Li L., Jin X., Geng P.

Narrative Review on Stroke Research, published in Neuroprotection (2025) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Narrative Review
Journal
Neuroprotection (2025)
Reported sample size
—
Source database
Europe PMC
PMID
41394308
PMCID
PMC12699548
DOI
10.1002/nep3.70012

Abstract (original English)

Stroke can cause motor sensory impairment and cognitive impairment. Current interventions focus on thrombolysis or thrombectomy in the acute stage, and promoting the recovery of neurological function during the chronic stage. However, so far, the effect on ischemic brain injury has been limited. Many patients do not receive timely and effective treatment, resulting in high rates of disability and mortality worldwide. In recent years, basic studies have shown that stem cells and their exosomes have a good effect on the protection of nerve function in ischemic brain injury, which has attracted the attention of researchers. This review describes the progress of the work on the stem cells and exosomes in ischemic stroke, in particular, the promising therapy of exosomes.

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is a narrative review: it collects no new patient data and does not systematically appraise evidence quality.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research